- Keyence forecasts a fiscal year dividend of 350.00 yen, falling short of the estimated 388.93 yen.
- Fourth-quarter operating income rose by 13% year-over-year to 152.74 billion yen, slightly surpassing the estimate of 152.12 billion yen.
- Net income for the fourth quarter increased by 3.6% year-over-year to 106.89 billion yen, but did not meet the estimated 110.29 billion yen.
- Net sales in the fourth quarter were 283.96 billion yen, up 9.2% year-over-year, but below the expected 287.99 billion yen.
- Yearly cash and deposits were recorded at 579.05 billion yen, which was lower than the estimated 706.04 billion yen.
- Inventories reached 77.89 billion yen, under the forecasted 84.92 billion yen.
- Analyst recommendations currently include 17 buy ratings, 2 holds, and no sell ratings for Keyence.
A look at Keyence Corp Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 4 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Keyence Corp shows a promising long-term outlook. With above-average scores in growth and resilience, the company appears well-positioned to capitalize on future opportunities and navigate challenges effectively. Keyence Corp‘s strong focus on innovation and adaptability further enhances its potential for sustained growth.
Keyence Corp‘s emphasis on developing cutting-edge technologies for factory automation and high-tech hobby products underscores its commitment to staying ahead in the market. While the company may not score as high in value or dividend factors, its solid performance in growth, resilience, and momentum bodes well for its overall competitiveness and sustainability in the industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
